NCT03168984

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian Subjects

A Single-Centre, Investigator/Subject Blind, Placebo-Controlled, Single and Multiple Oral Dose Investigation of Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: UCB Biopharma S.P.R.L. · Industry
• Sex: All
• Age: 20 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of the study is to evaluate the pharmacokinetics, safety and tolerability of UCB0942 in Japanese and Caucasian subjects.

Conditions

• Healthy Japanese and Caucasian Subjects

Interventions

Type	Name	Description
DRUG	UCB0942	* Pharmaceutical form: Film-coated tablet * Route of administration: Oral use
OTHER	Placebo	* Pharmaceutical form: Film-coated tablet * Route of administration: Oral use

Timeline

• Start date: 2017-05-05
• Primary completion: 2017-08-14
• Completion: 2017-08-14
• First posted: 2017-05-30
• Last updated: 2017-08-22

Locations

1 site across 1 country: United Kingdom